Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed, ...

For the prospective study, researchers analyzed data from 5,622 BIOBADADERM registry patients who underwent 11,368 treatment cycles across 21,762 person-years, using propensity score matching to ...